FORA Capital LLC Takes $484,000 Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

FORA Capital LLC purchased a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 12,197 shares of the company’s stock, valued at approximately $484,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ACHC. Tidal Investments LLC raised its stake in shares of Acadia Healthcare by 7.9% during the third quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock valued at $296,000 after acquiring an additional 340 shares in the last quarter. Franklin Resources Inc. grew its position in shares of Acadia Healthcare by 273.1% during the 3rd quarter. Franklin Resources Inc. now owns 105,228 shares of the company’s stock worth $6,673,000 after buying an additional 77,027 shares in the last quarter. Principal Financial Group Inc. increased its stake in shares of Acadia Healthcare by 2.1% during the third quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock valued at $41,653,000 after buying an additional 13,368 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after acquiring an additional 454,044 shares in the last quarter. Finally, GAMMA Investing LLC lifted its stake in Acadia Healthcare by 259.6% in the fourth quarter. GAMMA Investing LLC now owns 2,384 shares of the company’s stock worth $95,000 after acquiring an additional 1,721 shares during the period.

Acadia Healthcare Stock Down 1.4 %

NASDAQ:ACHC opened at $23.87 on Friday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a twelve month low of $20.36 and a twelve month high of $82.41. The company has a market cap of $2.20 billion, a PE ratio of 7.83, a P/E/G ratio of 1.46 and a beta of 1.01. The company’s 50 day moving average is $26.57 and its two-hundred day moving average is $36.52.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on ACHC shares. Guggenheim started coverage on shares of Acadia Healthcare in a report on Wednesday, April 9th. They set a “buy” rating and a $36.00 price objective on the stock. Mizuho reduced their price target on Acadia Healthcare from $48.00 to $37.00 and set a “neutral” rating for the company in a research report on Tuesday, March 25th. KeyCorp cut their target price on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating on the stock in a research note on Monday, March 3rd. Bank of America decreased their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a research report on Friday, February 28th. Finally, Royal Bank of Canada cut their price objective on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a research report on Monday, March 3rd. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $50.39.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.